Ayala Pharmaceuticals Inc (ADXS)

[huskercatman123]

I disagree with the term "failure"; management error perhaps would possibly be better fitting. The first leg was very low dosage, someone once referred to this as mouse level dosage. Personally from my demented point of view I thought that our mouse level dosage probably had better results that the first attempt by Inovio. There was much speculation based on the mysterious patent filing that our second leg was probably going to show numbers somewhere around 79%; although management felt that there were too many women dropping out to adequately assess the final results.